Dossier Pre-Submission Review and Compliance

Regulatory authority queries often arise from dossier deficiencies. Our scientific team conducts in-depth dossier evaluations for pharmaceuticals, medical devices, and herbal products to ensure compliance and prevent rejections.

Full CTD/ACTD structural compliance assessment

eCTD sequence integrity and lifecycle compatibility checks

Granular module-by-module completeness and cross-referencing verification

In-depth Quality (CMC) documentation review aligned with ICH expectations.

API and Finished Pharmaceutical Product (FPP) data consistency assessment.

Stability data evaluation against climatic zone requirements.

Bioequivalence (BE) study applicability and compliance checks.

Labeling review (SmPC, PIL, packaging) against target market requirements.

Identification of country-specific deficiencies across target markets (including emerging and SRA-aligned jurisdictions).

Risk-based classification of gaps impacting approval timelines.

Actionable, regulator-oriented remediation strategies.

Direct support in dossier correction and alignment.

Fully harmonized and technically validated dossier.

Optimized for first-cycle approval success.

Reduced query cycles and accelerated time-to-market.

Our review framework integrates structured validation logic aligned with global standards (CTD/eCTD, ICH guidelines, and leading pharmacopoeias), enabling consistent, scalable, and audit-ready dossier assessments.